Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00782652 · ClinicalTrials.gov registry record · Phase 2
The Effects of Nitric Oxide for Inhalation in Right Ventricular Infarction Patients
A Phase 2 study, sponsored by Mallinckrodt.
- Terminated
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT00782652 is a Phase 2 study that was terminated before completion, run by Mallinckrodt. The registered enrollment target is 3 participants.
The verdict
NCT00782652, a Phase 2 study, was terminated before completion, sponsored by Mallinckrodt.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
This study is designed to better understand the effects of nitric oxide, a gas for inhalation, on patients with right ventricular infarction.
Interventions
- DRUG inhaled nitric oxide
- DRUG nitrogen gas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2006-03 |
| Est. Completion | 2007-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00782652
The ClinicalTrials.gov registry entry for NCT00782652 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mallinckrodt, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which inhaled nitric oxide is the first listed.
NCT00782652 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00782652 about?
NCT00782652 is a clinical study titled "The Effects of Nitric Oxide for Inhalation in Right Ventricular Infarction Patients". This study is designed to better understand the effects of nitric oxide, a gas for inhalation, on patients with right ventricular infarction.
What is the current status of trial NCT00782652?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2006-03. Estimated completion is 2007-02.
What interventions are being tested in trial NCT00782652?
The interventions under investigation include: inhaled nitric oxide (DRUG), nitrogen gas (DRUG).
Who is sponsoring clinical trial NCT00782652?
This trial is sponsored by Mallinckrodt, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.